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ABSTRACT: Allosteric regulation of enzymatic activity forms
the basis for controlling a plethora of vital cellular processes.
While the mechanism underlying regulation of multimeric
enzymes is generally well understood and proposed to
primarily operate via conformational selection, the mechanism
underlying allosteric regulation of monomeric enzymes is
poorly understood. Here we monitored for the ﬁrst time
allosteric regulation of enzymatic activity at the single molecule
level. We measured single stochastic catalytic turnovers of a
monomeric metabolic enzyme (Thermomyces lanuginosus
Lipase) while titrating its proximity to a lipid membrane that
acts as an allosteric eﬀector. The single molecule measurements revealed the existence of discrete binary functional states that
could not be identiﬁed in macroscopic measurements due to ensemble averaging. The discrete functional states correlate with the
enzyme’s major conformational states and are redistributed in the presence of the regulatory eﬀector. Thus, our data support
allosteric regulation of monomeric enzymes to operate via selection of preexisting functional states and not via induction of new
ones.
■ INTRODUCTION
Allosteric regulation of enzymatic activity is central for
controlling a plethora of biological transformations vital for
living organisms. The process of regulation is achieved through
interactions with an eﬀector, ligand or another protein, at a site
distal from the active site.1−5 A central question, however, is
how these eﬀector interactions lead to regulation of enzymatic
activity. To address this question, two competing models have
been employed describing the regulation of multimeric
enzymes. The KNF model proposes eﬀector interactions on
one enzyme binding-site to sequentially “induce” new
conformational states on the rest of the monomers aﬀecting
their activity.6 The MWC model, on the other hand, proposes
multimeric enzymes to undergo reversible transitions between
discrete conformations assumed to have well-deﬁned activity.
Eﬀector interactions are proposed to shift the equilibrium
distribution by “selecting” one state with its corresponding
activity.7
While the mechanism underlying regulation of multimeric
enzymes is generally well described by these models, the
mechanism underlying regulation of monomeric enzymes
remains unclear.1,2,5,8 Current understanding primarily relies
on bulk measurements that correlate changes in macroscopic
activity with the redistribution of conformational equilibrium
upon regulation. Bulk kinetics, however, cannot directly
measure the inherent activity of each conformational state
because they report the time-average macroscopic activity of an
ensemble of enzymes. The existence of discrete functional
states, their correlation to conformational states, and the
putative selection or induction of a new functional state upon
regulation could only be directly conﬁrmed by single molecule
studies. Thus, to date it remains unknown whether regulatory
cofactors (a) redistribute a preexisting conformational equili-
brium without changing the inherent activity of each conforma-
tional state, (b) induce a new conformational state with its
corresponding inherent activity, or (c) operate via a
convolution of both mechanisms a and b.
Here, to identify the mechanism underlying regulation of
monomeric enzymes, we followed for the ﬁrst time regulation
Received: February 11, 2012
Published: April 10, 2012
Article
pubs.acs.org/JACS
© 2012 American Chemical Society 9296 dx.doi.org/10.1021/ja3011429 | J. Am. Chem. Soc. 2012, 134, 9296−9302
of enzymatic catalysis at the single molecule level. We used
measurements and statistical analysis of single catalytic
events9−17 to reveal the changes in the energy barriers along
both the reaction and the regulatory coordinate, of a
monomeric metabolic enzyme (Thermomyces lanuginosus
lipase) whose activity we regulated in a quantitative and
progressive manner by titrating its proximity to a lipid
membrane. We identiﬁed the existence of discrete functional
states that are linked to the enzyme’s conformational states, and
we found regulatory interactions to redistribute the probability
to reside in these states but not to introduce new functional
states. Our data thus support regulation of enzymatic activity to
operate through selection and not via induction of new
functional states, suggesting a mechanism akin to “conforma-
tional selection” (CS) rather than the “induced ﬁt” (IF)
hypothesis.
■ RESULTS
TLL is a representative model of metabolic enzymes whose
function is the degradation of fat.18 Similarly to other enzymes
such as GTPases,19 kinases,4 proteases,20 and phospholi-
pases,21,22 TLL undergoes a conformational rearrangement
upon regulation. When TLL interacts with its eﬀector, a lipid
membrane, the peptide-lid that otherwise blocks the active site
is displaced, rendering TLL catalytically competent.23 This well-
studied conformational rearrangement is of regulatory nature
and thus distinct from conformational interconversions along
the reaction coordinate.24,25
As shown in Figure 1A, we coupled TLL on surface-tethered
liposomes.26−29 Liposomes have been successfully employed to
encapsulate and study single molecules.30 Here we employed
these architectures as a scaﬀold bringing the enzyme in
proximity to its eﬀector23 while simultaneously minimizing
nonspeciﬁc interactions with the solid surface that may alter its
activity. To ensure a homogeneous, directional, immobilization
of all enzymes, we site-speciﬁcally biotinylated a well-
characterized single cysteine mutant of TLL31 that was
subsequently conjugated to a ﬂuorescently labeled streptavidin
and then tethered to the biotinylated liposomes (see
Supporting Information (SI) Figures S1−3).
To locate enzymes and monitor single enzymatic turnovers
in time, we used confocal ﬂuorescent microscopy.9−17 Labeling
ﬂuorescently both the liposomes (DiD) and the enzymes
(Alexa ﬂuor 488) allowed us to measure the stoichiometry of
the complexes and exclude from our measurements empty
liposomes or enzymes bound nonspeciﬁcally to the surface
(Figure 1B and C). We ensured that only one enzyme is
immobilized per liposome by using a stoichiometry of ∼1:20,
thus making it statistically unlikely (P < 10−3) for a liposome to
contain a second enzyme (SI Figure S4). To monitor the
enzymatic activity, we employed the preﬂuorescent substrate of
carboxy-ﬂuorescein diacetate (CFDA) (SI Figures S5−6),
which upon hydrolysis generates the highly ﬂuorescent product
carboxy-ﬂuorescein (FAM).11 After addition of a saturating
concentration of substrate (Figure S6), a single TLL
immobilized on a liposome was positioned under the parked
beam of the confocal microscope. Each enzymatic turnover
produced a ﬂuorescent burst before FAM diﬀused away from
the confocal volume, providing the stochastic trajectory of
single turnover events of Figure 1D. Positioning the laser on
empty vesicles provided the background signal (Figure 1D,
black trace). Special care was taken to ensure that (a) product
release from enzyme was not rate limiting, (b) product did not
accumulate on the liposomes, and (c) product did not blink in
the time scale of our measurements (see SI Figures S7−9).
Inspired by the conformational selection hypothesis, we
employed a previously reported two-state statistical model32 to
describe stochastic single-substrate turnovers; see the SI for
detailed statistical analysis. A catalytic cycle begins when a
substrate binds reversibly with the enzyme to form the
enzyme−substrate complex. The complex yields the product
with a rate kact1, and the enzyme rapidly recovers to the original
state. Once in the initial state, the enzyme either performs
another catalytic cycle or interconverts to a second conforma-
tional state with diﬀerent inherent activity (kact2) (green
enzyme in Figure 2A). At saturating substrate concentrations
where kact becomes the rate-limiting step, the probability
density of the waiting time (pw) between two adjacent turnover
cycles can be described by the following:
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Figure 1. Assay to monitor membrane-regulated enzymatic processes
at the single molecule level using ﬂuorescent microscopy. (A)
Schematic of the method. A single lipase (TLL) conjugated to a
labeled streptavidin is coupled to liposomes through a ﬂexible PEG-
biotin linker. The liposomes are tethered on the glass coverslip
passivated by streptavidin. A single preﬂuorescent substrate is
enzymatically converted to the ﬂuorescent product and is detected
before it diﬀuses away from the confocal volume. (B, C) Zoom in a
representative ﬂuorescent micrograph showing respectively liposomes
labeled with DiD and TLL enzymes labeled with Alexa ﬂuor488. The
low enzyme/liposome ratio ensures that only one enzyme is
immobilized per liposome. (D) Time trace of product formation
from a single TLL (red trace). Each spike corresponds to single
product formation. Control trace obtained from a liposome containing
no enzyme for identical substrate concentration (black trace). No
product accumulation on vesicle occurs. The detected photons are
binned at 1 ms in both cases. The time trace histogram shown on the
right-hand side of the trajectory is used to quantify the threshold
between consecutive enzyme turnovers.
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the average activity of a single enzyme is given by
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To examine whether the two-state model describes well the
activity of TLL, we analyzed pw, the enzyme’s contribution to
the in tens i t y au tocor re l a t ion (Cs(τ)) , Cs(τ) =
⟨Is(t)⟩2[(k12k21(kact1 − kact2)2)/(kact1k21 − kact2k12)2)]e − (k12
+ k21)τ, and the autocorrelation of waiting times (Cn) Cn =
(⟨τnτ1⟩ − ⟨τ1⟩2)/(⟨τ12⟩ − ⟨τ1⟩2). Similar to earlier observations
recorded at saturating conditions, we obtained a nonexponen-
tial decay of the waiting time distribution, a behavior previously
attributed to multiple reaction rates.9−15 Interestingly, we found
the double exponential of eq 1 to ﬁt accurately the experimental
data (see Figure 2B and SI Figure S23 for full data), and
furthermore so, signiﬁcantly better than the stretched
exponential decay previously employed to describe continuous
multistate activity models (see SI for detailed ﬁtting and
comparison between the two models). Additionally both Cs(t)
and Cn showed a monoexponential decay (Figure 2C and
Figures S14−15, see SI for full description), consistent with the
presence of two functional states.9
Next we examined whether additional enzymes possess a
discrete number of functional states. We obtained published
activity traces for β-galactosidase from E. coli,9 for the Nitrite
reductase (NR) from Alcaligenes faecalis,10 and for bovine
chymotrypsin,12 and we recorded the activity of the non-bilayer
regulated Lipase from Candida Antarctica (CALB). In agree-
ment with previous ﬁndings, β-galactosidase and chymotrypsin
could not be ﬁtted with a two-state model (see SI Figure
S26).9,12 This is expected for β-galactosidase, which is
composed of four monomers that could catalyze independently
of each other. We found however both NR and CALB, see SI
and Figures S23−25, to exhibit two discrete activity states in
agreement with TLL. Out of the four monomeric enzymes
reexamined here, three exhibited behavior that could be
explained by two activity state model which may raise questions
on the interpretation of single enzymes studies supporting the
existence of multiple activity states.9−15The two-state model
permitted us to quantify the inherent activity of discrete states
instead of a distribution of activities9−15 (see Table S2). This
was achieved by combining information from pw and Cn (see SI
for statistical analysis and Figures S12−14). We found TLL to
interconvert between states of signiﬁcantly diﬀerent inherent
activities kact1 = 0.23 ± 0.03 ms
−1 and kact2 = 0.0125 ± 0.003
ms−1. Since kact2 is on the average ∼20 times smaller than kact1,
it can be approximated as practically zero and the binary
enzymatic states can be described as digital-like, i.e. an active
and a practically inactive state (see SI Table S3 and Figure
S19). These functional states correlate well with the two major
conformational states of TLL, since the inactive state can be
assigned to the closed lid conformation while the highly active
state to the open lid conformation.33,34 It is noteworthy that the
lid dynamics in TLL are not taking place along the reaction
coordinate, as recently shown for other enzymes;24,25 in the
open state, the enzyme’s active site is substrate accessible, and
multiple turnovers may occur.4,35
Next we calculated the interconversion rates between the two
functional states. The extracted kinetic constants k12 = 0.062
ms−1 and k21 = 0.003 ms
−1 are in agreement with earlier studies
on protein dynamics showing domain motions occurring on the
microsecond to millisecond time scale,24 supporting the link
between functional and structural states. As a consistency
check, we examined Cs(t), which for the two activity states
model should decay monoexponentially (Figure 2C) with an
exponent that equals the sum of the two interconversion
rates.9,32 Indeed, the exponent of the intensity autocorrelation
decay K(I) = 0.06 ± 0.001 ms
−1 equals the sum of
interconversion rates k12 + k21 = 0.065 ± 0.03 ms
−1 (see SI
Figure S15 and Table S2). An alternative method employed to
quantify activity ﬂuctuations is the activity autocorrelation
K(t).9 We found, however, the time dependence of K(t) to
strongly depend on the averaging function used to calculate k2,
Figure 2. Two-state model describing well the stochastic activity
pattern of TLL. (A) Schematic representation of a general two-state
model employed to describe the catalytic behavior of enzymes. The
model is an extension on the Michaelis−Menten equation containing
two activity states (A1 and A2) with respective activity rates kact1 and
kact2. (B) Histogram of the waiting time between consecutive turnovers
of TLL obtained at saturating conditions plotted on a log−linear scale
(black dots) (see SI Figure S23 for all data). The red line is the double
exponential decay (see eq 1) that derives from the two-state model.
The blue line is the ﬁtting obtained with a stretched exponential decay
widely employed to ﬁt distributions resulting from multiple reaction
rates. A substantial improved ﬁtting is observed with the two-state
model. (C) Intensity autocorrelation of TLL plotted on a log−linear
scale. Cs(t) decays monoexponentially with an exponent that matches
the sum of the interconversion rates in agreement with the presence of
two discrete activity states. (D) (Black trace) Running average of TLL
waiting time in a moving window with a width of ∼2 s. TLL’s average
activity is not constant but ﬂuctuates in all time scales around an
average value as shown for multiple single enzymes. (Red trace) Time
trace of average TLL waiting time as simulated by using the parameters
extracted by the two-activity states model. An enzyme oscillating
between two activity states in the millisecond time scale may exhibit
activity ﬂuctuations occurring in slower (sec) time scales. Thus,
dynamic disorder is not a prerequisite of multiple activity states.
Journal of the American Chemical Society Article
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thus not providing any further information not encoded in the
intensity autocorrelation function Cs(t) (see SI for detailed
statistical analysis).
Plotting the time average of the waiting time between events
revealed that the millisecond activity ﬂuctuations of TLL extend
to the second time scales (Figure 2D). Activity oscillations in
multiple time scales (millisecond to second) were observed
previously and were interpreted to be the consequence of a
wide distribution of activity rates,9−15 we thus next examined
whether they may also result from a two-state system. Indeed,
when we simulated the waiting time using the parameters
extracted from ﬁtting our data, we observed activity ﬂuctuations
very similar to the experimental ones in terms of mean value,
time scale, and amplitude (Figure 2D and SI Figures S16−18).
Thus, activity ﬂuctuations in multiple time scales may well
originate from stochastic oscillations between two activity
states.2
Recent studies36 proposed the static heterogeneity of activity
between individual enzymes to originate from very slow
interconversion between conformational states of diﬀerent
activity; albeit, such transitions were not recorded. Within the
time scale of our measurements and for the number of
interrogated enzymes, we also did not observe such transitions.
If, however, a transition to a new long-lived activity state would
occur, it would result in a new set of the four rates (kact1, kact2,
k12, and k21) and thus to a systematic shift of the activity
oscillations around a new average value.
A basic consequence of our ﬁndings is that in the limiting
case of digital-like activity (i.e. when kact2 ≪ kact1, which can be
approximated as kact2→0), k2 as measured by ensemble
measurements and single molecule experiments would be the
product of the enzyme’s probability to reside on the highly
active state (Pact) and the inherent activity of the active state
(kact1).
= + − ⎯ →⎯⎯⎯⎯⎯⎯ =→k P k P k K P k(1 )act act act act
k
act act2 1 2
0
2 1
act2
(6)
The compelling question we addressed next is whether
allosteric regulation of k2 proceeds via redistribution of the
equilibrium between states, thus changing Pact, as the CS
hypothesis posits, by introduction of a new highly active state,
thus altering kact1, as the IF hypothesis posits, or by a
convolution of both. Hence, we monitored the activity of single
TLL while we modulated systematically its access to the
eﬀector-bilayer. TLL is an interfacially activated enzyme, and its
activity is allosterically regulated by the bilayer. In solution the
enzyme’s active site is blocked by the peptide-lid. Upon
interaction with a bilayer, TLL undergoes a major conforma-
tional rearrangement, and the lid rotates around its hinge
facilitating binding to the bilayer and exposing the enzymes
active site.23 This conformational rearrangement allows
substrate access to the active site and renders the enzyme in
a catalytically competent form. One way to modulate TLL’s
access to its eﬀector is to sterically hinder its access to the
bilayer. Alternatively the same could be achieved by altering the
length of the tether. Here we choose to modulate the enzymes
access to its eﬀector-bilayer by using the well established
methodology of imposing steric hindrance.37 By gradually
increasing the percentage of a polyethylene glycol (PEG
modiﬁed phospholipid in the liposome-scaﬀold (Figure 3A and
B and SI Figure S20) between 0 and 2.1% molar, we gradually
restricted the enzyme’s access to the bilayer. In a control
experiment we veriﬁed that PEG does not interfere directly
with enzymatic activity (see SI Figures S10 and 11). At 2.1%
molar PEG we found TLL to exhibit a residual activity rate of
∼7 s−1 (Figure 3C). Increasing enzyme’s access to the bilayer
resulted in a ∼4-fold exponential increase of activity to a
maximum of ∼26 s−1, in good agreement with bulk
measurements23 (see SI Figures S10−11).
Furthermore, we found Pact to depend strongly on the
regulatory eﬀect of the bilayer (Figure 3D). Systematically
hindering bilayer-access progressively shifted the equilibrium of
active/inactive states, reducing Pact from ∼0.4 to ∼0.15. The
reduction of Pact explains entirely the change in k2 (Figure 3C)
and can be ﬁtted well with the calculated, exponentially
decaying, probability of a protein to reach a PEG-covered
surface37 (see also SI). Interestingly, Figure 3D reveals that for
all degrees of regulation TLL molecules were found to have
constant kact1 (inherent activity) within error; see SI for all data.
Figure 3. Mechanistic origin of lipase activity regulation. (A, B)
Schematic representation (not to scale) of the experimental set up
employed to control in a systematic fashion TLL’s accessibility to the
eﬀector-bilayer. (A) At low PEG phospholipids concentration TLL has
unlimited access to the bilayer. (B) At high PEG concentrations the
bilayer is highly hindered. (C) Incrementing the PEG concentration
on liposomes results in a progressive ∼4-fold exponential decrease of
the enzymatic reaction rate, in good agreement with the probability of
the enzyme to access the bilayer (see SI). Each data point is the
average value of at least four individual single enzyme experiments (see
SI Table S1). (D) Deconvolution of the parameters that govern TLL
activity regulation. Independently of the PEG concentration, the
enzyme exhibits a constant within uncertainty activity kact1. Restricting
the enzyme’s accessibility to the bilayer results in exponential decay of
Pact. Thus, enzyme’s regulation does not occur via an increased
inherent enzymatic activity (kact1) but rather predominantly depends
on increased probability of residing in active states (Pact). (E) Origin of
energy landscape stabilization upon interaction with the eﬀector.
Incrementing the enzyme’s accessibility to the bilayers progressively
confers a relative energetic stabilization of the active state by 1.2kBT.
Error bars in parts C, D, and E represent the standard deviation for
diﬀerent single molecules.
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These data thus provide direct evidence that regulatory
interactions do not introduce a new functional state, as a
mechanism based on induced ﬁt would premise.
To analyze quantitatively the changes in the free energy
(ΔG) of TLL upon regulation, we used the microscopic rate
constants (see Table S1) and the Arrhenius equation (ΔG =
−kBT ln(k12/k21)). Increasing bilayer-access was found to
decrease progressively the ΔG of the two states in favor of the
active state to a ﬁnal value of 1.2kBT, which is in line with
earlier studies on protein dynamics24 (see Figure 3E and SI
Figure S21). Next we plotted k12 and k21 as a function of PEG
concentration (SI Figure S21). We found a strong dependency
on bilayer accessibility for k21 that was present despite the large
inhomogeneity in the rates, while k12 remained constant within
error. Because the inactive state corresponds to a closed-lid
state obtained for the enzyme residing in solution, its energy
level should be independent of accessing the bilayer and can
thus be taken as a reference point in our energy landscape
(Figure 4). Under this assumption, we conclude that regulation
of TLL is achieved by simultaneous and equal energetic
stabilization of the active state and of the energy barrier
between the two states (Figure 4, regulatory coordinate).5,38 An
additional control experiment would be to introduce additional
mutations that shift the conformational equilibrium toward one
of the states.39 However, these mutations would also alter the
enzyme’s energy landscape, prohibiting us from directly
comparing the free energy diﬀerence between the two variants.
The fact that kact1 remained constant (Figure 3D) independent
of bilayer accessibility suggests that the presence of the eﬀector
stabilizes equally the active state and the reaction transition
energy (Figure 4, reaction coordinate).
■ CONCLUSIONS
Historically, selective stabilization between preexisting con-
formational states was proposed to explain the allosteric
regulation of multisubunit enzymes and proteins, such as
aspartate transcarboamylase and hemoglobin.1 Later studies,
both in bulk and with single molecule resolution, proposed
monomeric proteins to operate through conformational
selection.3,38,40−45 The same mechanism was successfully
borrowed for monomeric enzymes to explain substrate
mediated conformational redistributions along the reaction
coordinate.2,5,25,46
Regulated enzymes, however, in addition to their reaction
coordinate, have a conformational-regulatory coordinate. A
major structural rearrangement has to occur for the enzyme to
adopt the active conformational state, where the active site is
accessible and catalysis may occur.4,21,47 Indeed, the existence
of discrete active and inactive conformational states has been
documented for multiple monomeric regulated en-
zymes.4,21,35,47 However, to date there is limited knowledge
whether eﬀectors simply redistribute the equilibrium of
preexisting conformational states,35,47,48 introduce a new
conformational state,49 or a convolution of the above. In either
case, the eﬀect of allosteric interactions on the enzymatic
reaction coordinate (see Figure 4) and thus on the enzyme’s
functional states cannot be quantiﬁed by experiments in bulk
due to ensemble averaging.
Studies on enzymatic activity regulation are based primarily
on structural evidence, and it is intuitively assumed that each
enzymatic major conformational state has a well-deﬁned
activity. However, all single molecule activity measurements
on nonregulated enzymes have instead provided evidence, and
interpretations thereof, supporting the existence of a con-
tinuous distribution of activity states.9−15 This putative absence
of discrete functional states indicates that the intuitive, albeit
nonvalidated, assumption of one to one correspondence
between conformational and functional states may not hold.
To resolve this problem, we decided to look for the eﬀect of
regulation on functional states directly, arguing in addition that,
in the case of regulation, function is a more important
observable compared to structure. In that sense, here we are
discussing “functional selection” instead of “conformational
selection”.
To test for the existence of discrete functional states, we
employed single enzyme kinetics,9−15 since their presence
would be masked in experiments in bulk. One central ﬁnding of
this work that sets the foundation for unraveling the
mechanism of enzymatic activity regulation is the identiﬁcation
of discrete functional states, which does not any longer
preclude selection as a regulatory mechanism. The presence of
two functional states furthermore supports the simpliﬁcation of
two state models employed by ensemble techniques such as
NMR to describe protein behavior.
In this study to monitor allosteric regulation of enzymatic
activity with single molecule resolution, we have employed a
novel platform based on arrays of surface tethered lip-
osomes.26−29 Liposomes constitute an ideal biocompatible
scaﬀold to spatially conﬁne practically any biocatalyst
minimizing denaturating interactions with hard matter that
may alter its function and permit reproducible measurements of
single enzyme kinetics. This generic platform can thus be
Figure 4. Changes in the free energy landscape of TLL upon
regulation. Quantiﬁcation of the eﬀect of regulatory interactions on the
energy landscape of both the regulatory coordinate (vertical axis) and
the reaction coordinate (horizontal axis) of TLL. Eﬀector interactions
remodel the regulatory coordinate by equal energetic stabilization of
the active state and the energy barrier to the active state by 1.2kBT
(green versus black one-dimensional cross section of the energy
landscape), thus redistributing the equilibrium and increasing the
probability to reside on the highly active state (shown as blue in the
cartoon inset). Regulation also energetically favors the transition state
to the product formation by 1.2kBT, thus maintaining a constant
inherent activity of the highly active state independent of regulatory
interactions.
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extended to investigate protein ligand or protein membrane
interactions as well as the behavior of regulated or not enzymes
with single molecule resolution. Titrating, for example, the
concentration of the water-soluble small molecule eﬀector
would allow studying the mechanism of allosteric regulation of
nonbilayer dependent enzymes. Altering bilayer properties such
as lipid charge, composition, and phase state would permit
investigating their eﬀect on the behavior of bilayer-regulated
enzymes. Here we used this platform to titrate the enzymes'
proximity to its eﬀector-bilayer and decipher the mechanism of
allosteric regulation using single molecule experiments.
Our single molecule ﬁndings extending beyond the reaction
coordinate allowed us to quantify the free energy landscape of
allosteric regulation of enzymatic activity. Besides calculating
energy barriers along the reaction coordinate,24,25,50 we
quantiﬁed for the ﬁrst time energy barriers along the regulatory
coordinate.4,40,51,52 We found regulatory interactions to equally
stabilize the highly active functional state and the reaction
transition energy. These ﬁndings thus demonstrate regulation
of TLL activity to operate via selection of preexisting functional
states. Since we did not measure the induction of new
functional states, our data support the prevalence of a
mechanism akin to “conformational selection” over the
“induced ﬁt” hypothesis.
The actual activity ratio (RA) of the two activity states of TLL
was ∼20, suggesting they could indeed form the basis of an
intramolecular binary switch of activity. RA plays a critical role
in regulation, since it poses the upper limit to the eﬃciency of
the process (Emax = 1 − 1/RA) that is reached for 100% eﬃcient
conformational selection. Obviously if RA = 1, regulation of
activity through conformational selection is not feasible (Emax =
0). For TLL, Emax = 0.95, making it a candidate for digital-like
regulation;23 however, under in vitro conditions, a less than
perfect regulation eﬃciency (ER = (Pact(max) − Pact(min))/Pact(max)
= 0.77) resulted in an overall eﬃciency ET = EmaxER = 0.73.
Out of a total of seven enzymes measured with single
turnover resolution to date,9−15 we screened ﬁve, four of which
where monomeric (including TLL; see SI), for the presence of
discrete functional states. Three of the monomeric enzymes
could be ﬁtted with a two-state model and are thus, in principle,
compatible with a mechanism akin to conformational selection.
The existence of a minimum number of functional states is
consistent with bulk ﬁndings on regulated proteins, thus
bringing into line single molecule work with ensemble studies.
Further measurements will reveal whether redistribution
between discrete preexisting functional states is a unifying
mechanism or whether other monomeric enzymes operate
through more complex regulatory principles.
Providing insights on the determinants of enzymatic
regulation is essential both for understanding cellular processes
and for the design of novel biocatalysts with tailor-made
functionalities.
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